234 related articles for article (PubMed ID: 9581552)
1. Tetramerization domain of human butyrylcholinesterase is at the C-terminus.
Blong RM; Bedows E; Lockridge O
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):747-57. PubMed ID: 9581552
[TBL] [Abstract][Full Text] [Related]
2. Conserved aromatic residues of the C-terminus of human butyrylcholinesterase mediate the association of tetramers.
Altamirano CV; Lockridge O
Biochemistry; 1999 Oct; 38(40):13414-22. PubMed ID: 10529218
[TBL] [Abstract][Full Text] [Related]
3. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.
Duysen EG; Bartels CF; Lockridge O
J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740
[TBL] [Abstract][Full Text] [Related]
4. Association of tetramers of human butyrylcholinesterase is mediated by conserved aromatic residues of the carboxy terminus.
Altamirano CV; Lockridge O
Chem Biol Interact; 1999 May; 119-120():53-60. PubMed ID: 10421438
[TBL] [Abstract][Full Text] [Related]
5. Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers.
Li H; Schopfer LM; Masson P; Lockridge O
Biochem J; 2008 Apr; 411(2):425-32. PubMed ID: 18076380
[TBL] [Abstract][Full Text] [Related]
6. Proline-Rich Chaperones Are Compared Computationally and Experimentally for Their Abilities to Facilitate Recombinant Butyrylcholinesterase Tetramerization in CHO Cells.
Wang Q; Chen CH; Chung CY; Priola J; Chu JH; Tang J; Ulmschneider MB; Betenbaugh MJ
Biotechnol J; 2018 Mar; 13(3):e1700479. PubMed ID: 29024569
[TBL] [Abstract][Full Text] [Related]
7. Polyproline promotes tetramerization of recombinant human butyrylcholinesterase.
Larson MA; Lockridge O; Hinrichs SH
Biochem J; 2014 Sep; 462(2):329-35. PubMed ID: 24916051
[TBL] [Abstract][Full Text] [Related]
8. The butyrylcholinesterase K-variant shows similar cellular protein turnover and quaternary interaction to the wild-type enzyme.
Altamirano CV; Bartels CF; Lockridge O
J Neurochem; 2000 Feb; 74(2):869-77. PubMed ID: 10646540
[TBL] [Abstract][Full Text] [Related]
9. Effect of polyethylene glycol modification on the circulatory stability and immunogenicity of recombinant human butyrylcholinesterase.
Chilukuri N; Sun W; Naik RS; Parikh K; Tang L; Doctor BP; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):255-60. PubMed ID: 18603232
[TBL] [Abstract][Full Text] [Related]
10. Tetramer-organizing polyproline-rich peptides differ in CHO cell-expressed and plasma-derived human butyrylcholinesterase tetramers.
Schopfer LM; Lockridge O
Biochim Biophys Acta; 2016 Jun; 1864(6):706-714. PubMed ID: 26947244
[TBL] [Abstract][Full Text] [Related]
11. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2007 Sep; 17(9):681-5. PubMed ID: 17700357
[TBL] [Abstract][Full Text] [Related]
12. Resistance of butyrylcholinesterase to inactivation by ultrasound: effects of ultrasound on catalytic activity and subunit association.
Froment MT; Lockridge O; Masson P
Biochim Biophys Acta; 1998 Sep; 1387(1-2):53-64. PubMed ID: 9748500
[TBL] [Abstract][Full Text] [Related]
13. The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.
Podoly E; Shalev DE; Shenhar-Tsarfaty S; Bennett ER; Ben Assayag E; Wilgus H; Livnah O; Soreq H
J Biol Chem; 2009 Jun; 284(25):17170-17179. PubMed ID: 19383604
[TBL] [Abstract][Full Text] [Related]
14. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase.
Biberoglu K; Tacal Ö; Akbulut H
Arch Biochem Biophys; 2011 Jul; 511(1-2):64-8. PubMed ID: 21530486
[TBL] [Abstract][Full Text] [Related]
15. Asp7O in the peripheral anionic site of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Eur J Biochem; 1996 Jan; 235(1-2):36-48. PubMed ID: 8631355
[TBL] [Abstract][Full Text] [Related]
16. Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure.
Brazzolotto X; Wandhammer M; Ronco C; Trovaslet M; Jean L; Lockridge O; Renard PY; Nachon F
FEBS J; 2012 Aug; 279(16):2905-16. PubMed ID: 22726956
[TBL] [Abstract][Full Text] [Related]
17. DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase.
Boeck AT; Schopfer LM; Lockridge O
Biochem Pharmacol; 2002 Jun; 63(12):2101-10. PubMed ID: 12110369
[TBL] [Abstract][Full Text] [Related]
18. Amino acid residues at the N- and C-termini are essential for the folding of active human butyrylcholinesterase polypeptide.
Naik RS; Pattabiraman N; Patel KA; Doctor BP; Saxena A
Chem Biol Interact; 2013 Mar; 203(1):24-9. PubMed ID: 23044488
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.
Primo-Parmo SL; Bartels CF; Wiersema B; van der Spek AF; Innis JW; La Du BN
Am J Hum Genet; 1996 Jan; 58(1):52-64. PubMed ID: 8554068
[TBL] [Abstract][Full Text] [Related]
20. Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization.
Nachon F; Nicolet Y; Viguié N; Masson P; Fontecilla-Camps JC; Lockridge O
Eur J Biochem; 2002 Jan; 269(2):630-7. PubMed ID: 11856322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
